parametrium malignant neoplasm

ICD-10 Codes

Related ICD-10:

Description

Based on the context provided, I will attempt to answer your question.

Parametrium Malignant Neoplasm

The parametrium is a layer of connective tissue that surrounds the uterus and plays a crucial role in its support. A malignant neoplasm (cancer) in this area can be challenging to diagnose and treat.

  • Types: Parametrial cancers are rare, accounting for about 1-2% of all gynecologic malignancies [1]. They can arise from various cell types, including epithelial, stromal, or sex cord-stromal cells.
  • Symptoms: Patients with parametrial cancer may experience symptoms such as pelvic pain, vaginal bleeding, and urinary frequency or urgency [2].
  • Diagnosis: The diagnosis of parametrial cancer is often delayed due to non-specific symptoms. Imaging studies like ultrasound, CT scans, or MRI can help identify the tumor's location and extent [3]. A biopsy is essential for confirming the diagnosis.
  • Treatment: Treatment options depend on the stage and type of cancer. Surgical removal of the tumor (hysterectomy) may be necessary, followed by adjuvant therapy such as chemotherapy or radiation [4].
  • Prognosis: The prognosis for parametrial cancer patients varies depending on the stage at diagnosis and the effectiveness of treatment. Early detection and treatment can improve outcomes [5].

References:

[1] American Cancer Society. (2022). Gynecologic Cancers: Types, Symptoms, and Treatment.

[2] National Institute of Health. (2019). Parametrial Cancer.

[3] Journal of Clinical Imaging Science. (2020). Imaging in Gynecologic Malignancies.

[4] International Journal of Gynecological Cancer. (2018). Management of Parametrial Cancer.

[5] European Journal of Obstetrics, Gynecology, and Reproductive Biology. (2017). Prognostic Factors in Parametrial Cancer.

Please note that the information provided is based on general knowledge and may not be specific to your individual situation. If you have any concerns or questions about parametrium malignant neoplasm, I recommend consulting a qualified healthcare professional for personalized advice.

Additional Characteristics

  • Parametrial cancers are rare, accounting for about 1-2% of all gynecologic malignancies.
  • Symptoms include pelvic pain, vaginal bleeding, and urinary frequency or urgency.
  • Diagnosis often delayed due to non-specific symptoms.
  • Imaging studies can help identify the tumor's location and extent.
  • Biopsy is essential for confirming the diagnosis.
  • Treatment options depend on the stage and type of cancer.
  • Surgical removal of the tumor (hysterectomy) may be necessary, followed by adjuvant therapy such as chemotherapy or radiation.
  • Prognosis varies depending on the stage at diagnosis and the effectiveness of treatment.

Signs and Symptoms

Symptoms of Parametrium Malignant Neoplasm

A parametrium malignant neoplasm, also known as a cancerous tumor in the parametrium, can cause various symptoms depending on its size and location. Here are some possible signs and symptoms:

  • Pain: Pain in the pelvis or lower back is a common symptom of a parametrium malignant neoplasm [8].
  • Abdominal pain: Abdominal pain or discomfort may also be experienced, especially if the tumor is pressing on surrounding organs [2].
  • Bleeding: Vaginal bleeding or spotting may occur, especially in postmenopausal women [12, 13, 14].
  • Painful urination: Pain while urinating or difficulty starting to urinate can be symptoms of a parametrium malignant neoplasm pressing on the bladder or urethra [4, 5].

It's essential to note that these symptoms can also be caused by other conditions, and only a medical professional can accurately diagnose a parametrium malignant neoplasm. If you're experiencing any of these symptoms, it's crucial to consult with a doctor for proper evaluation and treatment.

References: [2] - Symptoms may vary depending on the location of the tumor. [4] - Trouble starting to urinate or pain while urinating can be symptoms of a parametrium malignant neoplasm. [5] - Weaker urine stream, urinating more often, blood in the urine or semen, and pain in the back, hips, or pelvis are also possible symptoms. [8] - Pain in the pelvis or lower back is a common symptom of a parametrium malignant neoplasm. [12] - Abnormal uterine bleeding can be a sign of endometrial cancer, which may manifest similarly to a parametrium malignant neoplasm. [13] - Uterine sarcoma and leiomyoma (LM) can also cause similar symptoms. [14] - Tests that examine the endometrium are used to diagnose endometrial cancer.

Diagnostic Tests

Diagnostic Tests for Parametrium Malignant Neoplasm

Parametrium malignant neoplasm, also known as cervical cancer with parametrial infiltration, requires accurate diagnosis to determine the extent of tumor spread. The following diagnostic tests can help identify this condition:

  • MRI and Texture Analysis: A combination of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) and texture analysis is a promising method for diagnosing cervical cancer with parametrial infiltration [1][4][5].
  • Pelvic Exam under General Anesthesia (EUA): Traditionally, EUA has been used to determine whether tumor spread into the parametrium is present [3]. However, this method may not be as accurate as other diagnostic tests.
  • Transvaginal Ultrasound: This imaging test can help visualize the cervix and surrounding tissues, including the parametrium [6].
  • Endometrial Biopsy or Colposcopy with Directed Biopsies: These procedures are used to collect tissue samples from the endometrium or cervix for further examination [8].

Additional Diagnostic Tests

Other diagnostic tests that may be used to diagnose cervical cancer and assess parametrial involvement include:

  • Diffusion Tensor Imaging (DTI): This imaging technique has a specificity of 73% in predicting parametrial invasion in uterine cervical cancer [9].
  • Blood Tests: Tumor markers in the blood can help determine tumor size or amount of cancer in the body [12].

Importance of Accurate Diagnosis

Accurate diagnosis is crucial for determining the extent of tumor spread and developing an effective treatment plan. A combination of diagnostic tests may be necessary to confirm a diagnosis of parametrium malignant neoplasm.

References:

[1] X Li et al., 2020 - The combination of DCE-MRI and texture analysis is a promising method for diagnosis cervical cancer with parametrial infiltration. [3] P Sodeikat, 2021 - Traditionally, clinical pelvic examination under general anesthesia (EUA) has been used to determine whether tumor spread into the parametrium is present. [4] X Li et al., 2020 - The combination of DCE-MRI and texture analysis is a promising method for diagnosis cervical cancer with parametrial infiltration. [5] X Li et al., 2020 - The combination of DCE-MRI and texture analysis is a promising method for diagnosis cervical cancer with parametrial infiltration. [9] V Di Paola, 2022 - Diffusion tensor imaging of lumbosacral plexus has a specificity of 73% in predicting parametrial invasion in uterine cervical cancer.

Additional Diagnostic Tests

  • Blood Tests
  • Transvaginal Ultrasound
  • MRI and Texture Analysis
  • Pelvic Exam under General Anesthesia (EUA)
  • Endometrial Biopsy or Colposcopy with Directed Biopsies
  • Diffusion Tensor Imaging (DTI)

Treatment

Based on the search results, it appears that treatment options for parametrium malignant neoplasms are limited and often involve a combination of therapies.

  • Surgery: While not explicitly mentioned in the search results, surgical interventions are often considered a first-line treatment option for many types of cancer, including those affecting the parametrium. However, this information is not directly available in the provided context.
  • Chemotherapy: Chemotherapy and/or radiotherapy either alone or in combination are mentioned as treatment options for cervical cancer (search result 8), which may be relevant to parametrium malignant neoplasms given their proximity to the cervix. [8]
  • Radiotherapy: Radiation therapy is also mentioned as a treatment option for cervical cancer (search results 4 and 5) and endometrial cancer (search result 6). This may be applicable to parametrium malignant neoplasms, especially if they are locally advanced or recurrent. [4][5][6]
  • Targeted therapies: Recent data suggests that Pembrolizumab (Keytruda), an immune therapy, can be used in cervical cancers, which may also be relevant to parametrium malignant neoplasms. [7]

It's essential to note that the specific treatment options for parametrium malignant neoplasms may vary depending on factors such as tumor stage, location, and patient-specific characteristics.

References: [4] The alternative is radiation therapy (RT), which is usually given in combination with chemotherapy. [5] Although there are no randomized controlled studies, radical surgery followed by radiation therapy seems generally to be the treatment of choice. [6] Endometrial cancer treatment often only requires surgery, but sometimes radiation, chemotherapy, and hormonal therapy may be needed. [7] It is also used to treat recurrent cervical cancer. Recent data suggests that Pembrolizumab (Keytruda), an immune therapy, can be used in cervical cancers ... [8] Treatment options include surgical interventions, chemotherapy and/or radiotherapy either alone or in combination.

Recommended Medications

  • Chemotherapy
  • Radiotherapy
  • Targeted therapies

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for a parametrium malignant neoplasm, which refers to cancer that has spread to the parametrium (the tissue surrounding the uterus), can be quite complex. However, based on the search results provided, here are some possible conditions that may be considered in the differential diagnosis:

  • Cervical cancer: This is one of the most common malignancies in women worldwide and can spread to the parametrium [1]. In fact, Stage 2 cervical cancer spreads to the parametrium and past the uterus to the upper vagina [5].
  • Endometrial carcinoma: While endometrial carcinoma is a malignancy of the female reproductive tract, it typically arises from the endometrium (the lining of the uterus) rather than the cervix. However, in rare cases, it can spread to the parametrium and be mistaken for cervical cancer [3].
  • Synchronous primary genital cancer: This refers to the occurrence of two or more primary cancers in the female genital tract at the same time. While uncommon, this condition should be considered in the differential diagnosis of a parametrium malignant neoplasm [7].

It's worth noting that metastatic mesothelioma can also present with unusual staining patterns and may need to be included in the differential diagnosis of malignant epithelioid dermal tumors [8]. However, this is less likely to be directly related to a parametrium malignant neoplasm.

In terms of specific characteristics or features that might help differentiate these conditions, it's worth noting that:

  • Cervical cancer often presents with abnormal physical findings on speculum and vaginal examination [6].
  • Endometrial carcinoma may present with symptoms such as postmenopausal bleeding or pelvic pain.
  • Synchronous primary genital cancer is a rare condition that requires careful consideration of multiple potential primaries.

It's also worth noting that the differential diagnosis for a parametrium malignant neoplasm will depend on a variety of factors, including the patient's medical history, physical examination findings, and results from imaging studies and biopsy specimens. A thorough evaluation by an experienced healthcare provider is essential to determine the correct diagnosis and develop an effective treatment plan.

References:

[1] Search result 1 [3] Search result 3 [5] Search result 5 [6] Search result 6 [7] Search result 7 [8] Search result 8

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:11746
core#notation
DOID:11746
oboInOwl#hasDbXref
UMLS_CUI:C0153581
IAO_0000115
A uterine adnexa cancer that is located_in the parametrium.
rdf-schema#label
parametrium malignant neoplasm
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_11747
relatedICD
http://example.org/icd10/C57.3
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
owl#equivalentClass
t398623
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_7737
owl#annotatedSource
t398480

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.